Presented by: University of Kentucky Department of Pathology
“ From Concept to Impact:
Empowering the Future Pathology Workforce through Program-Building Initiatives”
Alisha D. Ware, M.D.
Assistant Professor, Department of Pathology
Johns Hopkins University School of Medicine
Thursday, December 18, 2025
12:00 – 1:00 pm
In-Person MS 147 or Zoom: http://us06web.zoom.us/j/89110280273? pwd=ybybn06jFDKtJzTCALTtz15lG8vhKV.1We
PASSCODE: 281106
Use the link to register: Pathology Grand Rounds 12/18/25 - Dr. Ware | UK HealthCare CECentral
At the completion of this lecture attendees should be able to:
- Discuss the importance of program-building initiatives
- Discuss the ways in which program-building initiatives can positively impact the pathology workforce
- Discuss the development and impact of past program-building initiatives
- Explain future initiatives
Disclosure of Financial Interest Summary to Learners
All planners, faculty, and others in control of educational content are required to disclose all their financial relationships with ineligible companies within the prior 24 months. An ineligible company is defined as one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if the educational content an individual can control is related to the business lines or products of the ineligible company.
None of the planners, faculty, and others in control of educational content for this educational activity have a relevant financial relationship(s) to disclose with ineligible companies.
The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include a discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speake rs will inform the audience when they are discussing investigational and/or off-label uses.
Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
- 1.00 AMA PRA Category 1 Credit™
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This Live activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
- 1.00 ParticipationUK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.

Facebook
X
LinkedIn
Forward